Landmark Sabra North America deployment targeting 20k beds
Filed with ASX · · 3 pages · English
Summary by 6ix AI
This partnership will facilitate PainChek's rollout in Sabra's skilled nursing and senior housing facilities, significantly reducing barriers to adoption. The agreement includes a pricing model that could be replicated across other real estate investment trusts in the region, enhancing PainChek's market penetration. CEO Philip Daffas expressed optimism about the accelerated uptake of PainChek within Sabra's network, indicating a strategic milestone for the company.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from PainChek
- PainChek reports material sales momentum in UK
- Half Yearly Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- PainChek Business Update
- PainChek gains access to RTM reimbursement in USA
Later from PainChek
- PainChek secures A$5.5m note to fund US expansion
- CEO Transition
- US MedTech leader Karen Holzberger appointed CEO
- PainChek receives $1.123 million R&D tax incentive refund
- Change of Director's Interest Notice x 4
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek